Review




Structured Review

Alnylam Inc aln app
Aln App, supplied by Alnylam Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aln+app/aln+app/pmc12908064-380-8-14
Average 86 stars, based on 1 article reviews
aln app - by Bioz Stars, 2026-09
86/100 stars

Images

Related Articles

other:

Article Title: Targeting Amyloid-β Proteins as Potential Alzheimer’s Disease Therapeutics: Anti-Amyloid Drug Discovery, Emerging Therapeutics, Clinical Trials and Implications for Public Health
Article Snippet: ALN-APP , Disease modifying biological agent , Aβ , RNAi to reduce APP and down-stream Aβ related events , Phase-1 , NCT05231785 , Feb-2022 , Jul-2025 , Alnylam Pharma.

Article Title: Recent Progress of Small Interfering RNA Delivery on the Market and Clinical Stage.
Article Snippet: Small interfering RNAs (siRNAs) are promising therapeutic strategies, and five siRNA drugs have been approved by the Food and Drug Administration (FDA) and the European Commission (EC).. This marks a significant milestone in the development of siRNA for clinical applications.. The approved siRNA agents can effectively deliver siRNAs to the liver and treat liver-related diseases.

Article Title: SCAD: A modular platform for efficient delivery of duplex RNA to the CNS and beyond
Article Snippet: For example, ALN-APP was the first CNS clinical program leveraging Alnylam’s C16 lipid conjugated-siRNA delivery platform designed to target the amyloid beta precursor ( APP ) gene via IT administration for treating early-onset Alzheimer’s disease and cerebral amyloid angiopathy ( NCT05231785 and NCT06393712 ).

Article Title: The landscape of nanoparticle-based siRNA delivery and therapeutic development
Article Snippet: ALN-APP , NA , PS, 2′-OMe, 2′-F , intrathecal , cerebral amyloid angiopathy , APP , preclinical , Alnylam Pharmaceuticals , NA.

Conjugation Assay:

Article Title: Overcoming the blood‒brain barrier: nanomedicine strategies for targeted delivery and multimodal therapy in Alzheimer's disease
Article Snippet: .. Alnylam has developed ALN-APP, an RNAi drug that targets APP , which uses proprietary C16-siRNA conjugation technology to enhance CNS delivery, with related patents filed (Brown et al. ; ClinicalTrials.gov. ..

Transformation Assay:

Article Title: Brain-targeted delivery of siRNA via non-viral delivery systems, the therapeutic strategy for Alzheimer's disease—Unveiling challenges and prospects
Article Snippet: .. Early results from this phase I trial of ALN-APP ( NCT05231785 ) demonstrate that Alnylam's proprietary C16-siRNA conjugate platform has achieved the first human clinical transformation in CNS delivery and is the first clinical demonstration of RNA therapy silencing disease-causing genes in the human brain. ..



Similar Products

86
Alnylam Inc aln app
Aln App, supplied by Alnylam Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aln+app/aln+app/pmc12908064-380-8-14
Average 86 stars, based on 1 article reviews
aln app - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

86
Alnylam Inc aln app utilizes alnylam
Aln App Utilizes Alnylam, supplied by Alnylam Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aln+app/aln+app/pm41599628-256-0-2
Average 86 stars, based on 1 article reviews
aln app utilizes alnylam - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

86
Alnylam Inc aln app small interfering rna sirna program
Aln App Small Interfering Rna Sirna Program, supplied by Alnylam Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aln+app/aln+app/pm40770764-114-5-4
Average 86 stars, based on 1 article reviews
aln app small interfering rna sirna program - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

90
Alnylam Inc aln-app – mivelsiran
Aln App – Mivelsiran, supplied by Alnylam Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aln+app/aln+app+++mivelsiran/pm40506325-211-7-10
Average 90 stars, based on 1 article reviews
aln-app – mivelsiran - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Alnylam Inc mivelsiran (aln-app)
Mivelsiran (Aln App), supplied by Alnylam Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aln+app/aln+app+++mivelsiran/pm40340000-154-8-11
Average 90 stars, based on 1 article reviews
mivelsiran (aln-app) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results